Respiratory Syncytial Virus (RSV) Therapeutics Market 2024-Global Industry Analysis, by Key Players, Segmentation, Trends and Forecast by 2031

The Respiratory Syncytial Virus (RSV) Therapeutics Market was valued at USD 5.75 billion in 2023 and is projected to attain USD 15.28 billion by 2031, with a predicted compound annual growth rate (CAGR) of 13% during the forecast duration spanning from 2024 to 2031.

author avatar

0 Followers
23, May 24 4 min read 0 comments 19 views
Bookmark Report
Respiratory Syncytial Virus (RSV) Therapeutics Market 2024-Global Industry Analysis, by Key Players, Segmentation, Trends and Forecast by 2031
Share blog posts from your blog
Top
Share blog posts from your blog
Comments (0)
Login to post.